[go: up one dir, main page]

CN108096632A - Articular cartilage repair materials and preparation method based on oxidized hyaluronic acid-II Collagen Type VIs and self concentration bone marrow nucleated cell - Google Patents

Articular cartilage repair materials and preparation method based on oxidized hyaluronic acid-II Collagen Type VIs and self concentration bone marrow nucleated cell Download PDF

Info

Publication number
CN108096632A
CN108096632A CN201711446501.2A CN201711446501A CN108096632A CN 108096632 A CN108096632 A CN 108096632A CN 201711446501 A CN201711446501 A CN 201711446501A CN 108096632 A CN108096632 A CN 108096632A
Authority
CN
China
Prior art keywords
bone marrow
hyaluronic acid
collagen
type
add
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201711446501.2A
Other languages
Chinese (zh)
Other versions
CN108096632B (en
Inventor
刘俊利
曾伟南
曾平
曾一平
谭祖键
周明全
贾小林
张胜利
郝玉徽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
People's Hospital Of Chongqing City
Original Assignee
People's Hospital Of Chongqing City
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by People's Hospital Of Chongqing City filed Critical People's Hospital Of Chongqing City
Priority to CN201711446501.2A priority Critical patent/CN108096632B/en
Publication of CN108096632A publication Critical patent/CN108096632A/en
Application granted granted Critical
Publication of CN108096632B publication Critical patent/CN108096632B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843Connective tissue
    • A61L27/3852Cartilage, e.g. meniscus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0669Bone marrow stromal cells; Whole bone marrow
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/06Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/06Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Materials For Medical Uses (AREA)

Abstract

本发明涉及一种基于氧化透明质酸‑II型胶原和自体浓缩骨髓有核细胞的关节软骨修复材料及制备方法,由氧化透明质酸、II型胶原蛋白和自体浓缩骨髓有核细胞制成,材料中的自体浓缩骨髓有核细胞具有自我更新及成软骨分化潜能,参与软骨缺损修复,因此具有很好的软骨损伤修复效果,修复组织呈透明软骨样,修复组织表面平整度、与邻近正常软骨的整合程度、II型胶原蛋白含量、GAG含量、钙化软骨层及软骨下骨形态等方面均明显优于空白对照组,有临床转化的潜能。

The invention relates to an articular cartilage repair material based on oxidized hyaluronic acid-type II collagen and autologous concentrated bone marrow nucleated cells and a preparation method thereof, which is made of oxidized hyaluronic acid, type II collagen and autologous concentrated bone marrow nucleated cells. The autologous enriched bone marrow nucleated cells in the material have the potential of self-renewal and chondrogenic differentiation, and participate in the repair of cartilage defects, so they have a good repair effect on cartilage damage. The degree of integration, type II collagen content, GAG content, calcified cartilage layer and subchondral bone morphology were significantly better than those of the blank control group, and had the potential for clinical transformation.

Description

基于氧化透明质酸-II型胶原和自体浓缩骨髓有核细胞的关 节软骨修复材料及制备方法Based on the relationship between oxidized hyaluronic acid-type II collagen and autologous enriched bone marrow nucleated cells Articular cartilage repair material and preparation method

技术领域technical field

本发明属于医学材料领域,涉及基于氧化透明质酸-II型胶原和自体浓缩骨髓有核细胞的关节软骨修复材料,还涉及该材料的制备方法和应用。The invention belongs to the field of medical materials, and relates to an articular cartilage repair material based on oxidized hyaluronic acid-II collagen and autologous concentrated bone marrow nucleated cells, and also relates to a preparation method and application of the material.

背景技术Background technique

关节软骨是衬附在关节表面的薄层致密结缔组织,其表面光滑,质地坚固而富有弹性,是人体关节重要的负重组织。而正常的关节软骨由于无血管、神经及淋巴分布,损伤后难以自行修复,至今仍然缺乏有效的修复策略。而临床工作中,关节软骨损伤的发生率较高,Widuchowski回顾性分析25,124例膝关节镜手术病例,发现60%病例存在软骨损伤。软骨损伤已成为导致关节疼痛、功能障碍甚至肢体残疾的重要原因。现阶段临床常用的损伤软骨修复策略主要包括:关节腔清理、微骨折、软骨移植、软骨细胞移植、骨软骨移植等,但以上修复策略长期疗效欠佳,治疗效果难以令人满意。软骨组织工程技术是关节软骨损伤修复较为理想的方法,但现阶段组织工程技术用于软骨修复仍存在诸多问题,如:程序较复杂;修复组织力学属性较差、与宿主组织整合欠佳以及纤维软骨退变等。因此,探索更为简便且具有更优修复效果的软骨组织工程策略具有重要意义。Articular cartilage is a thin layer of dense connective tissue lining the surface of joints. Its surface is smooth, firm and elastic, and it is an important load-bearing tissue for human joints. However, since normal articular cartilage has no blood vessels, nerves, and lymphatic distribution, it is difficult to repair itself after injury, and there is still a lack of effective repair strategies. In clinical work, the incidence of articular cartilage damage is relatively high. Widuchowski retrospectively analyzed 25,124 cases of arthroscopic knee surgery and found that 60% of the cases had cartilage damage. Cartilage damage has become an important cause of joint pain, dysfunction and even physical disability. Currently, commonly used clinical repair strategies for damaged cartilage include: joint cavity debridement, microfracture, cartilage transplantation, chondrocyte transplantation, and osteochondral transplantation. Cartilage tissue engineering technology is an ideal method for the repair of articular cartilage damage, but there are still many problems in the use of tissue engineering technology for cartilage repair at this stage, such as: more complicated procedures; poor mechanical properties of repaired tissues, poor integration with host tissues, and fibrous Cartilage degeneration, etc. Therefore, it is of great significance to explore a simpler and better cartilage tissue engineering strategy.

发明内容Contents of the invention

有鉴于此,本发明的目的之一在于提供一种基于氧化透明质酸-II型胶原和自体浓缩骨髓有核细胞的关节软骨修复材料;本发明的目的之二在于提供基于氧化透明质酸-II型胶原和自体浓缩骨髓有核细胞的关节软骨修复材料的制备方法;本发明的目的之三在于提供基于氧化透明质酸-II型胶原和自体浓缩骨髓有核细胞的关节软骨修复材料的应用。In view of this, one purpose of the present invention is to provide a kind of articular cartilage repair material based on oxidized hyaluronic acid-II collagen and autologous concentrated bone marrow nucleated cells; the second purpose of the present invention is to provide a material based on oxidized hyaluronic acid-type II The preparation method of the articular cartilage repair material of type II collagen and autologous concentrated bone marrow nucleated cells; the third object of the present invention is to provide the application of articular cartilage repair materials based on oxidized hyaluronic acid-type II collagen and autologous concentrated bone marrow nucleated cells .

为达到上述目的,本发明提供如下技术方案:To achieve the above object, the present invention provides the following technical solutions:

1.基于氧化透明质酸-II型胶原和自体浓缩骨髓有核细胞的关节软骨修复材料,由氧化透明质酸、II型胶原蛋白和自体浓缩骨髓有核细胞制成。1. Articular cartilage repair material based on oxidized hyaluronic acid-type II collagen and autologous concentrated bone marrow nucleated cells, made of oxidized hyaluronic acid, type II collagen and autologous concentrated bone marrow nucleated cells.

优选的,氧化透明质酸、II型胶原蛋白和自体浓缩骨髓有核细胞的加入量按每5×106个自体浓缩骨髓有核细胞加入100mg II型胶原蛋白混合均匀,通过漩涡震荡及离心,去除混合凝胶内气泡,将10ul氧化透明质酸溶液加入复合细胞的II型胶原蛋白、凝胶中。Preferably, the amount of oxidized hyaluronic acid, type II collagen and autologous concentrated bone marrow nucleated cells is added to 5×10 6 autologous concentrated bone marrow nucleated cells, and 100 mg type II collagen is added to mix evenly, vortexed and centrifuged, Remove the air bubbles in the mixed gel, and add 10ul oxidized hyaluronic acid solution to the type II collagen and gel of compound cells.

优选的,所述100mg/ml的氧化透明质酸由每100mg氧化透明质酸加入1ml PBS溶液,经完全溶解制得。Preferably, the 100 mg/ml oxidized hyaluronic acid is prepared by adding 1 ml of PBS solution for every 100 mg oxidized hyaluronic acid and dissolving it completely.

更优选的,所述II型胶原蛋白由以下方法制备:将冻干软骨粉按质量体积比为20:1(g:L)用浓度为4M盐酸胍溶液搅拌混悬,搅拌后置于4℃条件下,消化软骨粉基质中的粘多糖至匀浆状态;消化完全后,将消化产物在4℃、8000rpm条件下离心20min,弃上清液,收集沉淀物,加水溶解,然后加入相当于盐酸胍溶液体积3/50倍的醋酸,加入相当于冻干软骨粉重量0.1倍的胃蛋白酶,加水至终体积为盐酸胍溶液的2倍,调节pH值于2.5-3之间,然后在4℃条件下消化48h;消化完毕后于立式高速离心机中8000rpm离心20min,弃沉淀,收集上清液;接着向上清液中缓慢倒入浓度为1.5M的NaOH溶液并搅拌至pH值为7.5时停止倒注,加入NaCl使其终浓度为3M,4℃条件下,8000rpm离心20min,收集沉淀物;沉淀物分装至透析袋中待透析液电导率,接近纯水电导率时结束透析;将透析袋内粘稠胶状溶液在4℃条件下,立式高速离心机8000rpm离心20min,收集沉淀物至无菌容量瓶中,加入0.15mol/L的盐酸溶液,溶解3天后白色沉淀蛋白分散、溶解呈凝胶状,搅拌均匀,分装,冻干,备用。More preferably, the type II collagen is prepared by the following method: freeze-dried cartilage powder is suspended in a 4M guanidine hydrochloride solution with a mass-volume ratio of 20:1 (g:L), and placed at 4°C after stirring Digest the mucopolysaccharides in the cartilage powder matrix under the same conditions to a homogenate state; after the digestion is complete, centrifuge the digested product at 4°C and 8000rpm for 20min, discard the supernatant, collect the precipitate, add water to dissolve, and then add equivalent hydrochloric acid Acetic acid 3/50 times the volume of the guanidine solution, adding pepsin equivalent to 0.1 times the weight of the freeze-dried cartilage powder, adding water until the final volume is twice the volume of the guanidine hydrochloride solution, adjusting the pH value between 2.5-3, and then heating at 4°C Digest for 48 hours under the same conditions; after digestion, centrifuge at 8000rpm in a vertical high-speed centrifuge for 20 minutes, discard the precipitate, and collect the supernatant; then slowly pour 1.5M NaOH solution into the supernatant and stir until the pH value is 7.5 Stop pouring, add NaCl to make the final concentration 3M, and centrifuge at 8000rpm for 20min at 4°C to collect the sediment; divide the sediment into dialysis bags and stop the dialysis when the conductivity of the dialysate is close to the conductivity of pure water; Centrifuge the viscous colloidal solution in the dialysis bag at 4°C in a vertical high-speed centrifuge at 8000rpm for 20min, collect the precipitate into a sterile volumetric flask, add 0.15mol/L hydrochloric acid solution, dissolve for 3 days, and then the white precipitated protein is dispersed, Dissolve in gel form, stir evenly, subpackage, freeze-dry, and set aside.

更优选的,所述氧化透明质酸由以下方法制备:配制成质量分数为2%的透明质酸溶液,然后加入0.1g/ml的高碘酸钠溶液,搅拌,避光条件下完全氧化反应6小时,然后加入乙二醇终止反应,再将反应液灌入透析袋中至电导率接近纯水时结束透析,获得氧化透明质酸。More preferably, the oxidized hyaluronic acid is prepared by the following method: prepare a hyaluronic acid solution with a mass fraction of 2%, then add 0.1 g/ml sodium periodate solution, stir, and completely oxidize under the condition of avoiding light After 6 hours, ethylene glycol was added to terminate the reaction, and then the reaction solution was poured into a dialysis bag until the conductivity was close to that of pure water, and the dialysis was terminated to obtain oxidized hyaluronic acid.

更优选的,自体浓缩骨髓有核细胞由以下方法制备:对目前动物进行麻醉,然后用已经使用1000U/ml肝素预湿的注射器抽取骨髓血,然后将抽取的抗凝骨髓液加入等体积的无菌PBS液,混匀,混匀后将骨髓液沿管壁缓慢注入到含等体积的浓度为1.073g/ml的Percoll胞分离液中,注入过程保持分离液与混合液体之间界面的完整,接着采用Percoll密度梯度离心法获取自体浓缩骨髓有核细胞,先以2000rpm的速度离心混合液体15min,吸取有核细胞层,加入PBS溶液洗涤吸取的有核细胞,以1500rpm的速度离心洗涤细胞5min,弃上清。再次加入PBS吹打洗涤细胞,1000rpm速度离心5min,弃上清,加入PBS重悬即得。More preferably, the autologous concentrated bone marrow nucleated cells are prepared by the following method: the current animal is anesthetized, and then the bone marrow blood is extracted with a syringe pre-wetted with 1000 U/ml heparin, and then the extracted anticoagulated bone marrow fluid is added to an equal volume of Bacterial PBS solution, mix well, slowly inject the bone marrow fluid along the tube wall into the Percoll cell separation solution containing an equal volume of concentration of 1.073g/ml, keep the interface between the separation solution and the mixed solution intact during the injection process, Then use Percoll density gradient centrifugation to obtain autologous concentrated bone marrow nucleated cells. First, centrifuge the mixed liquid at a speed of 2000rpm for 15min, absorb the nucleated cell layer, add PBS solution to wash the absorbed nucleated cells, and centrifuge and wash the cells at a speed of 1500rpm for 5min. Discard the supernatant. Add PBS again to wash the cells by pipetting, centrifuge at 1000rpm for 5min, discard the supernatant, and add PBS to resuspend.

2、所述基于氧化透明质酸-II型胶原和自体浓缩骨髓有核细胞的关节软骨修复材料的制备方法,具体步骤如下:将自体浓缩骨髓有核细胞先与II型胶原蛋白混合,然后再加入氧化透明质酸进行交联。2. The preparation method of the articular cartilage repair material based on oxidized hyaluronic acid-type II collagen and autologous concentrated bone marrow nucleated cells, the specific steps are as follows: first mix the autologous concentrated bone marrow nucleated cells with type II collagen, and then Oxidized hyaluronic acid is added for cross-linking.

3、所述基于氧化透明质酸-II型胶原和自体浓缩骨髓有核细胞的关节软骨修复材料在制备关节软骨修复材料中的应用。3. The application of the articular cartilage repair material based on oxidized hyaluronic acid-type II collagen and autologous concentrated bone marrow nucleated cells in the preparation of articular cartilage repair materials.

本发明的有益效果在于:本发明公开基于氧化透明质酸-II型胶原和自体浓缩骨髓有核细胞的关节软骨修复材料,该材料由氧化透明质酸、II型胶原蛋白和自体浓缩骨髓有核细胞制成,植入的自体浓缩骨髓有核细胞具有自我更新及成软骨分化潜能,参与软骨缺损修复,因此制得的材料对软骨损伤具有很好的修复效果,修复组织呈透明软骨样,修复组织表面平整度、与邻近正常软骨的整合程度、II型胶原蛋白含量、GAG含量、钙化软骨层及软骨下骨形态等方面均明显优于空白对照组,有临床转化的潜能。The beneficial effects of the present invention are: the present invention discloses an articular cartilage repair material based on oxidized hyaluronic acid-type II collagen and autologous concentrated bone marrow nucleated cells. The implanted autologous enriched bone marrow nucleated cells have the potential of self-renewal and chondrogenic differentiation, and participate in the repair of cartilage defects. Therefore, the prepared material has a good repair effect on cartilage damage. Tissue surface smoothness, degree of integration with adjacent normal cartilage, type II collagen content, GAG content, calcified cartilage layer and subchondral bone morphology were significantly better than those of the blank control group, and had the potential for clinical transformation.

附图说明Description of drawings

为了使本发明的目的、技术方案和有益效果更加清楚,本发明提供如下附图进行说明:In order to make the purpose, technical scheme and beneficial effect of the present invention clearer, the present invention provides the following drawings for illustration:

图1为SDS-PAGE电泳图(Lane1,Lane2和Lane3分别表示不同的上样量)。Figure 1 is an SDS-PAGE electrophoresis image (Lane1, Lane2 and Lane3 respectively indicate different loading amounts).

图2为II型胶原蛋白水凝胶摇菌实验。Figure 2 is a shaking experiment of type II collagen hydrogel.

图3为骨髓间充质干细胞图(A:培养2天贴壁间充质干细胞;B:传代P3的间充质干细胞)。Fig. 3 is a diagram of bone marrow mesenchymal stem cells (A: adherent mesenchymal stem cells cultured for 2 days; B: mesenchymal stem cells passaged at P3).

图4为II型胶原与间充质干细胞充分混合图(A:II型胶原与细胞共培养诱导;B:凝胶与间充质干细胞共培养)。Fig. 4 is a diagram showing sufficient mixing of type II collagen and mesenchymal stem cells (A: co-culture induction of type II collagen and cells; B: co-culture of gel and mesenchymal stem cells).

图5为HA和OHA傅立叶红外光谱。Figure 5 shows the Fourier transform infrared spectra of HA and OHA.

图6为CCK-8检测结果。Fig. 6 is the detection result of CCK-8.

图7为OHA-COLII-BMSC在模具中成胶结果。Figure 7 shows the gelation results of OHA-COLII-BMSC in the mold.

图8为猪骨髓间充质干细胞三系诱导结果(A:间充质干细胞成骨诱导;B:间充质干细胞成脂诱导;C:间充质干细胞软骨诱导)。Figure 8 shows the induction results of three lines of porcine bone marrow mesenchymal stem cells (A: osteogenic induction of mesenchymal stem cells; B: adipogenic induction of mesenchymal stem cells; C: chondrogenic induction of mesenchymal stem cells).

图9为OHA-COLII-BMSC成凝胶及培养不同时间切片结果(A:OHA-COLII-BMSC成凝胶结果;B:培养14小时后切片结果;C:培养21小时后切片结果;D:培养前凝胶切片结果;E:培养14小时凝胶切片结果;F:培养21天凝胶切片结果)。Figure 9 shows the results of gelation of OHA-COLII-BMSC and slices at different times of culture (A: gelation results of OHA-COLII-BMSC; B: slice results after 14 hours of culture; C: slice results after 21 hours of culture; D: Gel slice results before culture; E: gel slice results after 14-hour culture; F: gel slice results after 21-day culture).

图10为软骨修复组织评分结果(A:MOCART评分结果;B:O`Driscoll评分结果;C:ICRS评分结果)。Figure 10 is the scoring results of cartilage repair tissue (A: MOCART scoring results; B: O`Driscoll scoring results; C: ICRS scoring results).

图11为氧化透明质酸的制备及与II型胶原蛋白产生交联反应原理图。Fig. 11 is a schematic diagram of the preparation of oxidized hyaluronic acid and the cross-linking reaction with type II collagen.

具体实施方式Detailed ways

下面将结合附图,对本发明的优选实施例进行详细的描述。The preferred embodiments of the present invention will be described in detail below with reference to the accompanying drawings.

实施例1、氧化透明质酸II型胶原仿生凝胶的制备Example 1, Preparation of Oxidized Hyaluronic Acid Type II Collagen Biomimetic Gel

(1)软骨Ⅱ型胶原蛋白水凝胶的提取及鉴定(1) Extraction and identification of cartilage type II collagen hydrogel

a.制备软骨粉:获取新鲜贵州小香猪膝关节透明软骨,于-20℃冰箱冷冻12h,将冷冻软骨集于玻璃皿中,置于真空冷冻干燥机中,24h后冻干(温度降至-66℃,压强降至1Pa),冷冻干燥后软骨片,倒入液氮低温粉碎机,持续充入液氮,软骨片粉碎成干燥软骨粉末,收集软骨粉至密封袋保存待用;a. Preparation of cartilage powder: obtain the hyaline cartilage of the knee joint of fresh Guizhou Xiaoxiang pig, freeze it in a -20°C refrigerator for 12 hours, collect the frozen cartilage in a glass dish, place it in a vacuum freeze dryer, and freeze-dry it after 24 hours (the temperature drops to -66°C, pressure down to 1Pa), after freeze-drying, pour the cartilage slices into a liquid nitrogen low-temperature pulverizer, continuously fill with liquid nitrogen, crush the cartilage slices into dry cartilage powder, collect the cartilage powder and store it in a sealed bag for later use;

b.Ⅱ型胶原蛋白的提取:称取20g冻干软骨粉置于烧杯中,倒入1L 4M盐酸胍溶液搅拌混悬,磁力搅拌器持续搅拌并置于4℃冰箱中,消化软骨粉24h后基质中的粘多糖至匀浆状态;消化完全后,将消化产物在4℃离心8000rpm×20min,弃上清液,收集沉淀物至烧杯中,加水至1500ml刻度处,然后量取60ml醋酸加入烧杯中,加入2g胃蛋白酶,加水至2000ml刻度处,调节pH值于2.5-3之间,置于冰箱中4℃条件下磁力搅拌消化48h;胃蛋白酶消化完毕后于立式高速离心机中离心8000rpm×20min,弃沉淀,收集上清液;接着向上清液中缓慢倒入1.5M NaOH溶液并行搅拌至pH值为7.5时停止倒注,加入NaCl使其终浓度为3M,4℃条件下,离心8000rpm×20min,收集沉淀物;沉淀物分装至透析袋中(直径25mm,分子量3500),两端用尼龙线扎紧,双蒸水透析,前48h每6h更换一次透析液,之后每12h更换一次,总透析时间大约5d。电导率仪实时监测透析液电导率,待透析液电导率,低于生理盐水,接近纯水电导率时结束透析;将透析袋内粘稠胶状溶液移至离心筒,4℃条件下,立式高速离心机离心8000rpm×20min,收集沉淀物至无菌容量瓶中,加入0.15mol/L的盐酸溶液,溶解3天后白色沉淀蛋白分散、溶解呈凝胶状,搅拌均匀,在超菌工作台中,分装至不同容量灭菌玻璃密封瓶中,4℃保存待用;b. Extraction of Type II Collagen: Weigh 20g of freeze-dried cartilage powder and place it in a beaker, pour 1L of 4M guanidine hydrochloride solution into the suspension, stir continuously with a magnetic stirrer and place in a refrigerator at 4°C, digest the cartilage powder for 24 hours The mucopolysaccharide in the matrix is in a homogenized state; after the digestion is complete, centrifuge the digested product at 4°C at 8000rpm×20min, discard the supernatant, collect the precipitate into a beaker, add water to the 1500ml mark, and then measure 60ml of acetic acid into the beaker Add 2g of pepsin, add water to the mark of 2000ml, adjust the pH value between 2.5-3, and place it in the refrigerator at 4°C for 48h with magnetic stirring; after pepsin digestion, centrifuge in a vertical high-speed centrifuge at 8000rpm ×20min, discard the precipitate, collect the supernatant; then slowly pour 1.5M NaOH solution into the supernatant and stir until the pH value is 7.5, stop pouring, add NaCl to make the final concentration 3M, centrifuge at 4°C 8000rpm×20min, collect the sediment; divide the sediment into dialysis bags (diameter 25mm, molecular weight 3500), tie both ends tightly with nylon thread, dialyze with double distilled water, change the dialysate every 6h for the first 48h, and then every 12h Once, the total dialysis time is about 5 days. The conductivity meter monitors the conductivity of the dialysate in real time. When the conductivity of the dialysate is lower than that of normal saline and close to the conductivity of pure water, the dialysis ends; Centrifuge at 8000rpm×20min in a type high-speed centrifuge, collect the sediment into a sterile volumetric flask, add 0.15mol/L hydrochloric acid solution, and dissolve the white precipitated protein after 3 days. , divided into sterilized glass sealed bottles of different volumes, and stored at 4°C for later use;

取适量胶原蛋白水凝胶进行冻干,按公式(湿重-挥发液体重量)/(湿重体积),计算出II型胶原水凝胶w/v,结果显示,采用本实施例的方法制得II型胶原蛋白检测质量分数为10%(w/v)。Take an appropriate amount of collagen hydrogel for freeze-drying, and calculate type II collagen hydrogel w/v according to the formula (wet weight-volatilized liquid weight)/(wet weight volume). The detected mass fraction of type II collagen was 10% (w/v).

将提取的II型胶原蛋白经过SDS-PAGE凝胶电泳后,结果如图1所示。结果显示,提取的蛋白仅显示一条条带,随着上样量的增多,条带浓度呈梯度增强,条带分子量约120KD,为软骨II型胶原蛋白所特有蛋白条带,在其它分子量上无明显杂带显影,说明提取的II型胶原蛋白纯度较高。After the extracted type II collagen was subjected to SDS-PAGE gel electrophoresis, the results are shown in Figure 1. The results showed that the extracted protein showed only one band. As the amount of sample increased, the concentration of the band increased gradually. The molecular weight of the band was about 120KD, which was a unique protein band of cartilage type II collagen. Obvious miscellaneous band development indicates that the extracted type II collagen has a high purity.

II型胶原蛋白水凝胶用2M NaOH调节中性后,置于LB培养基中,多次进行摇菌实验,虽有部分胶原溶解于培养基中底部,但摇菌管中上部培养基透明清亮,与阳性和阴性管对比,均显示出无污染阴性结果(图2)。After the type II collagen hydrogel was neutralized with 2M NaOH, it was placed in LB medium, and the shaking experiment was carried out many times. Although some collagen was dissolved in the bottom of the medium, the medium in the upper part of the shaking tube was transparent and clear. , compared with the positive and negative tubes, both showed negative results without contamination (Figure 2).

骨髓间充质干经过密度梯度离心后,分离的细胞培养基进行重悬,培养2d换液冲洗掉漂浮淋巴细胞和红细胞,贴壁的细胞即为获取的骨髓间充质干细胞,细胞呈多角形、长梭形,原代细胞细胞分裂象多见(图3中A),4-5天后即形成多个细胞集落。经过传代培养后,细胞增长更加旺盛,长梭形细胞经5-7天在培养瓶中即可形成80%-90%细胞融合度,呈编织状、漩涡状排列。(图3中B)After the bone marrow mesenchymal stem is subjected to density gradient centrifugation, the separated cell culture medium is resuspended, and the floating lymphocytes and red blood cells are washed away after being cultured for 2 days. The adherent cells are the obtained bone marrow mesenchymal stem cells, and the cells are polygonal , long fusiform, primary cell divisions are more common (A in Figure 3), and multiple cell colonies are formed after 4-5 days. After subculture, the cells grow more vigorously, and the elongated spindle cells can form 80%-90% cell fusion in the culture flask after 5-7 days, and are arranged in a weaving and swirl shape. (B in Figure 3)

II型胶原与间充质干细胞充分混合后,凝胶块可沉浸于培养基中,少量凝胶块可发生溶解,但并非污染引起的浑浊,更换培养基时需小心更换,避免吹打,凝胶块以物理连接团聚,强度较低,结构松散(图4中A)。在光学显微镜下照相可见胶原纤维排列松散,在凝胶块边缘可见丝样胶原纤维,长短均一,在凝胶块的细胞呈圆形,脱落于培养板上的细胞变延长,开始分裂增殖。(图4中B)After the type II collagen and mesenchymal stem cells are fully mixed, the gel pieces can be immersed in the medium, and a small amount of gel pieces can be dissolved, but it is not turbid due to pollution. When changing the medium, be careful to replace it, avoid blowing, and the gel The blocks are agglomerated with physical connections, with low strength and loose structure (A in Fig. 4). Photographs under an optical microscope show that the collagen fibers are loosely arranged, silky collagen fibers can be seen on the edge of the gel block, and the length is uniform. (B in Figure 4)

(2)透明质酸的氧化(2) Oxidation of hyaluronic acid

透明质酸的氧化:取4g透明质酸溶解200ml纯水中,在磁力搅拌器上搅拌6h完全溶解,配制成质量分数为2%的透明质酸溶液,待用;取2g高碘酸钠加入20ml纯水中溶解后,倒入配制的2%透明质酸溶液中,持续搅拌,铝箔纸包裹避光,室温(18~25℃)环境下完全氧化反应6小时;量取乙二醇20ml加入烧杯中反应1h,终止氧化反应,将反应液灌入透析袋中(直径25mm,分子量3500),两端扎紧,双蒸水透析,前48h每6h更换一次透析液,之后每12h更换1次。电导率仪实时监测透析液电导率,待透析液电导率,接近纯水电导率时结束透析,获得氧化透明质酸,将透析液倒入冻干盘中置于-20℃冰箱中,预冷冻12h结冰后,置于真空冷冻干燥机中冷冻干燥24h(温度降至-66℃,压强降至1Pa),最后将干燥的氧化透明质酸以100mg为单位分装至EP管中,密封胶带密封,Co 60辐照消毒。Oxidation of hyaluronic acid: Dissolve 4g of hyaluronic acid in 200ml of pure water, stir on a magnetic stirrer for 6h to dissolve completely, and prepare a hyaluronic acid solution with a mass fraction of 2% for later use; take 2g of sodium periodate and add After dissolving in 20ml of pure water, pour it into the prepared 2% hyaluronic acid solution, keep stirring, wrap it in aluminum foil to avoid light, and completely oxidize it at room temperature (18-25°C) for 6 hours; measure 20ml of ethylene glycol and add React in a beaker for 1 hour to terminate the oxidation reaction, pour the reaction solution into a dialysis bag (diameter 25mm, molecular weight 3500), tie the two ends tightly, dialyze with double distilled water, change the dialysate every 6 hours for the first 48 hours, and then replace it every 12 hours . The conductivity meter monitors the conductivity of the dialysate in real time. When the conductivity of the dialysate is close to the conductivity of pure water, the dialysis is terminated to obtain oxidized hyaluronic acid. The dialysate is poured into a freeze-drying tray and placed in a -20°C refrigerator for pre-freezing After freezing for 12 hours, freeze and dry in a vacuum freeze dryer for 24 hours (the temperature drops to -66°C and the pressure drops to 1 Pa). Finally, the dried oxidized hyaluronic acid is divided into EP tubes in units of 100 mg, and sealed with tape Sealed and sterilized by Co 60 irradiation.

透明质酸经高碘酸钠氧化后呈透明液态,冻干后呈海绵状,将冻干的透明质酸和未经氧化的透明质酸,经溴化钾压片法,行傅立叶红外光谱检测,在波长1750发生特征性改变,表明透明质酸上的羟基被高碘酸钠特异性的氧化成醛基(图5)。Hyaluronic acid is in a transparent liquid state after being oxidized by sodium periodate, and is in the form of a sponge after freeze-drying. The freeze-dried hyaluronic acid and unoxidized hyaluronic acid are tested by Fourier infrared spectroscopy through potassium bromide tablet method , a characteristic change occurs at a wavelength of 1750, indicating that the hydroxyl group on the hyaluronic acid is specifically oxidized to an aldehyde group by sodium periodate (Figure 5).

将氧化后透明质酸可完全溶解于培养基中,猪骨髓间充质干细胞在0.5mg/ml,1.0mg/ml,1.5mg/ml氧化透明质酸培养体系中进行培养48h后,行CCK-8检测,与空白对照组进行对照无明显差异,证明其无明显细胞毒性和增殖活性减弱(图6)。The oxidized hyaluronic acid can be completely dissolved in the medium, and the porcine bone marrow mesenchymal stem cells are cultured in the 0.5mg/ml, 1.0mg/ml, 1.5mg/ml oxidized hyaluronic acid culture system for 48 hours, and then CCK- 8 detection, there was no significant difference compared with the blank control group, which proved that it had no obvious cytotoxicity and weakened proliferative activity (Fig. 6).

(3)氧化透明质酸II型胶原仿生凝胶的制备(3) Preparation of oxidized hyaluronic acid type II collagen biomimetic gel

a.取辐照消毒的氧化透明质酸100mg,加入1ml PBS溶液,使其完全溶解待用。a. Take 100 mg of oxidized hyaluronic acid sterilized by irradiation, add 1 ml of PBS solution, and dissolve it completely for use.

b.取1g II型胶原蛋白,加入75μl NaOH(2M),神经剥离子搅拌均匀,移液枪加入100μl溶解氧化透明质酸,充分搅拌。将其填充至不锈钢模具孔中(直径8mm,厚3mm),2min后氧化透明质酸II型胶原蛋白(OHA-COLII)完全成胶呈凝固状。置于-20℃冰箱中预冻24h后,置于真空冻干机中进行冻干呈海绵状。送至第三医科大学中心实验室,离子溅射仪给样品镀10nm金膜,扫描电镜观察剖面。其余凝胶块浸于生理盐水的培养皿中,置于37℃培养箱中培养14d,观察溶胀和溶解情况(图7)。b. Take 1g type II collagen, add 75μl NaOH (2M), stir the nerve strips evenly, add 100μl dissolved oxidized hyaluronic acid with a pipette gun, and stir well. Fill it into a stainless steel mold hole (diameter 8mm, thickness 3mm), and after 2 minutes, the oxidized hyaluronic acid type II collagen (OHA-COLII) is completely gelled and solidified. After pre-freezing in a -20°C refrigerator for 24 hours, freeze-dry in a vacuum freeze dryer to form a sponge. Sent to the Central Laboratory of the Third Medical University, the ion sputtering machine coated the sample with 10nm gold film, and the section was observed by scanning electron microscope. The rest of the gel pieces were soaked in a petri dish of physiological saline, placed in a 37° C. incubator and incubated for 14 days, and the swelling and dissolution were observed ( FIG. 7 ).

猪骨髓间充质干细胞三系诱导:取传代培养的间充质干细胞。Three-line induction of porcine bone marrow mesenchymal stem cells: subcultured mesenchymal stem cells.

a)成骨诱导:当细胞融合度达到80-90%时,用质量分数0.25%的胰酶进行消化;将消化下来的干细胞按照2×104cells/cm2的细胞密度接种六孔板中,接种前将孔板中放入0.1%明胶包被的玻片,每孔加入2mL完全培养基。当细胞融合度达到60-70%,将孔内完全培养基吸走。分别向六孔板中加入2mL成人骨髓间质干细胞成骨诱导分化完全培养基,每隔3d换液,诱导3w后茜素红进行染色。结果如图8中A所示,结果显示骨髓间充质干细胞经过成骨诱导后,分泌的钙结节被茜素红红染。a) Osteogenic induction: when the cell confluence reaches 80-90%, digest with 0.25% trypsin; inoculate the digested stem cells in a six-well plate at a cell density of 2×10 4 cells/cm 2 Before inoculation, put 0.1% gelatin-coated slides into the well plate, and add 2 mL of complete medium to each well. When the cell confluency reaches 60-70%, aspirate the complete medium in the well. Add 2 mL of adult bone marrow mesenchymal stem cell osteogenic induction and differentiation complete medium to the six-well plate, change the medium every 3 days, and stain with alizarin red after 3 weeks of induction. The results are shown in A in Figure 8, and the results show that the calcium nodules secreted by bone marrow mesenchymal stem cells were stained with alizarin red after osteogenic induction.

b)成脂诱导:细胞接种方法同上,细胞融合度达到100%,将间质干细胞完全培养基吸走,向六孔板中加入2ml骨髓间充质干细胞成脂诱导分化培养基A液。诱导3d后,吸走六孔板中的A液,加入2ml骨髓间质干细胞成脂诱导分化培养基B液。24h后,吸走B液,换回A液进行诱导。A液和B液交替作用4次后(15d),继续用B液维持培养5d直到脂滴变得足够大、圆,固定后油红O染色。结果如图8中B所示,结果显示经过成脂诱导后,细胞胞体变大,细胞铺展,细胞核淡染,细胞浆内产生大量的脂肪颗粒,较大的脂肪颗粒可发生融合,形成脂肪滴。b) Adipogenic induction: the cell inoculation method is the same as above, the degree of cell fusion reaches 100%, the complete medium of mesenchymal stem cells is sucked away, and 2ml of bone marrow mesenchymal stem cell adipogenic induction differentiation medium A is added to the six-well plate. After 3 days of induction, liquid A in the six-well plate was sucked away, and 2 ml of bone marrow mesenchymal stem cell adipogenic differentiation medium liquid B was added. After 24 hours, liquid B was sucked away, and liquid A was replaced for induction. After 4 times (15 days) of alternating action of solution A and solution B, the culture was continued with solution B for 5 days until the lipid droplets became sufficiently large and round, and stained with Oil Red O after fixation. The results are shown in Figure 8 B. The results show that after adipogenic induction, the cell body becomes larger, the cells spread, the nuclei are lightly stained, and a large number of fat particles are produced in the cytoplasm, and the larger fat particles can fuse to form fat droplets. .

c)成软骨诱导:细胞接种方法同上,细胞融合度达到100%,将间质干细胞完全培养基吸走,向六孔板中加入2ml骨髓间充质干细胞成软骨诱导分化培养基,培养21d,固定后阿立新兰染色。染色后用镊子取出六孔板中玻片,在光学显微镜下拍照观察诱导情况;结果如图8中C所示,结果显示成软骨诱导后,间充质干细胞形态发生改变,由长梭形变为铺路石样,分泌GAG被阿里新兰染成浅蓝色,细胞核不着色。c) Chondrogenic induction: the cell inoculation method is the same as above, the degree of cell fusion reaches 100%, the complete medium of mesenchymal stem cells is sucked away, and 2ml of bone marrow mesenchymal stem cell chondrogenic induction differentiation medium is added to the six-well plate, cultured for 21 days, Alcian blue staining after fixation. After staining, take out the glass slide in the six-well plate with tweezers, and take pictures under the optical microscope to observe the induction situation; the results are shown in Figure 8 C, and the results show that after chondrogenic induction, the morphology of mesenchymal stem cells changes, from long spindles to Paving stone-like, secreted GAGs were stained light blue by Alixinlan, and the nuclei were not stained.

取培养至第三代的猪骨髓间充质干细胞,倒掉培养基,PBS冲洗2遍后,0.25%胰酶消化3min,细胞呈球状,轻拍瓶壁细胞脱落悬浮,2ml完全培养基终止消化。1000rpm×3min离心后,2ml培养基重悬,细胞计数板计数细胞,取5×106再次离心至2ml EP管中。取1g调至中性的COLII加至离心细胞的EP管中,加入100μl溶解OHA,充分搅拌均匀,将凝胶填充至高温消毒后的不锈钢模具中,2min后待其成凝胶状,即OHA-COLII-BMSC。置于完全培养基中,在孔板中进行培养。结果表明,OHA-COLII-BMSC能够在无菌模具中很好的成凝胶(图9中A)。Take porcine bone marrow mesenchymal stem cells that have been cultured to the third generation, discard the medium, rinse with PBS twice, digest with 0.25% trypsin for 3 minutes, the cells are spherical, pat the bottle wall cells to fall off and suspend, 2ml of complete medium to stop digestion . After centrifugation at 1000rpm×3min, resuspend in 2ml medium, count the cells on a cell counting board, take 5×10 6 and centrifuge again into a 2ml EP tube. Take 1g of neutralized COLII and add it to the EP tube of the centrifuged cells, add 100μl of dissolved OHA, stir well, fill the gel into a high-temperature sterilized stainless steel mold, and wait for 2 minutes for it to become a gel, that is, OHA -COLII-BMSC. Place in complete medium and culture in well plates. The results showed that OHA-COLII-BMSC could form a gel well in the sterile mold (A in Fig. 9).

在孔板中培养至14d,21d分别取标本,10%福尔马林固定24h后,行HE染色,在光学显微镜下观察切片情况;培养至第14d取标本一枚戊二醛固定,50%、70%、80%、90%乙醇梯度脱水各15min,再用100%乙醇脱水3次,每次30min;叔丁醇置换每次30min,共置换3次。冷冻干燥仪干燥样品,用双面胶带将样品粘到样品台上,离子溅射仪给样品镀10nm金膜,扫描电镜观察标本剖面情况。结果如图9所示,结果显示,培养14d、21d后在培养基中仍保持了凝胶的完整(图9中B和C),切片显示间充质细胞均匀分布于凝胶块中,无明显减少(图9中D、E和F)。固定后脱水,凝胶块固缩呈团块状,剖面扫面电镜显示固缩球形细胞分布于凝胶中(图9中A)。After culturing in the well plate for 14 days and 21 days, samples were taken respectively, fixed in 10% formalin for 24 hours, stained with HE, and observed under an optical microscope; when cultured to the 14th day, a sample was taken and fixed in 50% formalin. , 70%, 80%, and 90% ethanol gradient dehydration for 15 minutes each, and then dehydration with 100% ethanol three times, each time for 30 minutes; tert-butanol replacement for 30 minutes each time, a total of three replacements. A freeze dryer dries the sample, sticks the sample on the sample stage with a double-sided adhesive tape, coats the sample with a 10nm gold film by an ion sputtering instrument, and observes the profile of the sample with a scanning electron microscope. The results are shown in Figure 9. The results showed that after 14d and 21d of culture, the integrity of the gel was still maintained in the culture medium (B and C in Figure 9), and the section showed that the mesenchymal cells were evenly distributed in the gel block, without Significantly decreased (D, E and F in Figure 9). After dehydration after fixation, the gel block was condensed into a mass, and the section scanning electron microscope showed that the pyknotic spherical cells were distributed in the gel (A in Figure 9).

实施例2、仿生凝胶复合自体浓缩骨髓有核细胞修复软骨缺损实验Example 2. Experiment of repairing cartilage defect with biomimetic gel combined with autologous enriched bone marrow nucleated cells

为了探索仿生凝胶复合自体浓缩骨髓有核细胞修复关节软骨损伤的效果,设计了一步法修复软骨缺损的动物实验,通过仿生凝胶复合自体浓缩骨髓有核细胞修复猪膝关节软骨缺损。以贵州小香猪为实验动物,首先在全麻下于髂脊处抽吸获取骨髓,通过骨髓分离液分离获取自体浓缩骨髓有核细胞,并和II型胶原蛋白混合,再加入氧化透明质酸进行交联。通过手术方式于膝关节股骨滑车处制备直径为8mm的全厚软骨缺损模型,将混合细胞的水凝胶植入软骨缺损部位。术后1、3、6月通过MRI、大体观察、体视显微镜及病理切片进行观察分析。通过本部分动物实验,探索该策略修复软骨缺损的实验效果,验证该策略的可行性,为后期的临床运用提供基础。In order to explore the effect of biomimetic gel combined with autologous concentrated bone marrow nucleated cells in repairing articular cartilage damage, an animal experiment was designed to repair cartilage defects with a one-step method. The bionic gel combined with autologous concentrated bone marrow nucleated cells was used to repair pig knee articular cartilage defects. Taking Guizhou Xiaoxiang pigs as experimental animals, the bone marrow was first aspirated at the iliac crest under general anesthesia, and the autologous concentrated bone marrow nucleated cells were obtained through separation of bone marrow separation fluid, mixed with type II collagen, and then added with oxidized hyaluronic acid to cross-link. A full-thickness cartilage defect model with a diameter of 8 mm was prepared at the femoral trochlea of the knee joint by surgical means, and a hydrogel of mixed cells was implanted into the cartilage defect site. At 1, 3, and 6 months after operation, MRI, gross observation, stereomicroscope, and pathological sections were used for observation and analysis. Through this part of animal experiments, explore the experimental effect of this strategy in repairing cartilage defects, verify the feasibility of this strategy, and provide a basis for later clinical application.

具体实验方法如下:The specific experimental method is as follows:

将40头贵州小香猪按照随机数表法随机分为A、B两组,每组20膝,共40膝,避免修复关节继发性损伤,仅一侧关节施行手术;A组为空白对照组(单纯透明软骨缺损组);B组为实验组(II型胶原蛋白-氧化透明质酸水凝胶复合自体骨髓浓缩有核细胞修复组);每组膝关节于4个时间点(1、3、6及12月)取材进行观察、检测及评价,每个取材时间点选取5个膝关节样本。According to the random number table method, 40 Guizhou small pigs were randomly divided into two groups, A and B, with 20 knees in each group, a total of 40 knees, to avoid secondary damage to the repaired joints, and only one side of the joint was operated on; group A was the blank control group (simple hyaline cartilage defect group); group B was the experimental group (type II collagen-oxidized hyaluronic acid hydrogel combined with autologous bone marrow enriched nucleated cell repair group); knee joints in each group were treated at 4 time points (1, 3, 6 and 12 months) were collected for observation, detection and evaluation, and 5 knee joint samples were selected for each sampling time point.

贵州小香猪自体浓缩骨髓有核细胞的获取:肌注陆眠宁4ml进行基础麻醉,3%戊巴比妥钠溶液按0.2mL/kg剂量耳静脉注射,麻醉贵州小香猪;将麻醉后的贵州小香猪置于手术台上,取侧卧位,对侧髂前上棘区备皮、消毒、铺巾。使用16号骨髓穿刺针于髂嵴处刺入,感觉到落空感后再进针约1cm,取出针芯,用已经使用肝素(1000U/ml)预湿的20ml注射器(肝素2ml)抽取骨髓血。根据抽吸量的多少适当调整穿刺针的位置及深度,共抽吸约20ml,送实验室进行自体浓缩骨髓有核细胞分离;将抽取的抗凝贵州小香猪骨髓液注入50ml离心管中,再加入等体积的无菌PBS液,混匀。将混匀后的骨髓液沿离心管壁缓慢注入到含等体积的Percoll(1.073g/ml)细胞分离液中,注入过程缓慢进行,保持分离液与混合液体之间界面的完整。防止因速度过快使骨髓液与Percoll细胞分离液混合,影响分离效果。采用Percoll密度梯度离心法获取自体浓缩骨髓有核细胞:以2000rpm的速度离心混合液体15min,可见液体分层现象:自上至下分别为:血浆层、有核细胞层(含骨髓间充质干细胞)、透明分离液层及红细胞层。小心吸取有核细胞层(第2层的白色云雾状层)至新的离心管,加入10ml PBS溶液洗涤吸取的有核细胞,以1500rpm的速度离心洗涤细胞5min,弃上清。再次加入10ml PBS吹打洗涤细胞,1000rpm速度离心5min,弃上清。加入5ml PBS重悬,并使用细胞计数板行细胞计数,收集细胞备用;II型胶原蛋白复合骨髓浓缩有核细胞:取2×106个骨髓有核细胞,置于EP管,1000rpm的速度离心5min,弃上清,加入100mg II型胶原蛋白混合均匀,通过漩涡震荡及离心,去除混合凝胶内气泡待用。Acquisition of autologous enriched bone marrow nucleated cells from Guizhou Xiaoxiang pigs: Intramuscular injection of Lumianning 4ml for basic anesthesia, 3% pentobarbital sodium solution at a dose of 0.2mL/kg ear vein injection to anesthetize Guizhou Xiaoxiang pigs; anesthetize Guizhou Xiaoxiang pigs; Guizhou piglets were placed on the operating table in a lateral position, and the contralateral anterior superior iliac spine area was prepared, disinfected, and draped. Use a 16-gauge bone marrow puncture needle to pierce at the iliac crest, and then insert the needle for about 1 cm after feeling a void, take out the needle core, and draw bone marrow blood with a 20 ml syringe (heparin 2 ml) that has been pre-wetted with heparin (1000 U/ml). Properly adjust the position and depth of the puncture needle according to the amount of aspiration, aspirate about 20ml in total, and send it to the laboratory for separation of autologous concentrated bone marrow nucleated cells; inject the extracted anticoagulated Guizhou Xiaoxiang pig bone marrow fluid into a 50ml centrifuge tube, Then add an equal volume of sterile PBS solution and mix well. Slowly inject the mixed bone marrow fluid into the cell separation solution containing an equal volume of Percoll (1.073g/ml) along the wall of the centrifuge tube. The injection process is carried out slowly to keep the integrity of the interface between the separation solution and the mixed solution. Prevent the bone marrow fluid from mixing with the Percoll cell separation medium due to too fast speed, which will affect the separation effect. Autologous concentrated bone marrow nucleated cells were obtained by Percoll density gradient centrifugation: the mixed liquid was centrifuged at 2000rpm for 15 minutes, and the liquid stratification phenomenon was seen: from top to bottom: plasma layer, nucleated cell layer (including bone marrow mesenchymal stem cells) ), transparent separation fluid layer and red blood cell layer. Carefully draw the nucleated cell layer (the second white cloudy layer) into a new centrifuge tube, add 10ml of PBS solution to wash the absorbed nucleated cells, centrifuge and wash the cells at 1500rpm for 5min, and discard the supernatant. Add 10ml of PBS again to wash the cells by pipetting, centrifuge at 1000rpm for 5min, and discard the supernatant. Add 5ml PBS to resuspend, and use a cell counting plate to count the cells, collect the cells for later use; type II collagen complex bone marrow nucleated cells: take 2× 106 bone marrow nucleated cells, put them in EP tubes, and centrifuge at 1000rpm After 5 minutes, the supernatant was discarded, and 100mg type II collagen was added to mix evenly, and the air bubbles in the mixed gel were removed by vortexing and centrifugation.

然后进行动物手术,具体步骤如下:Then carry out animal surgery, the specific steps are as follows:

a.抽取骨髓后于对侧膝部理发器剪毛备皮,备皮范围大小约为40cm×30cm,用无菌纱布蘸抗菌洗手液反复擦洗术区至清洁无污物,碘伏壶喷洒术区。将手术动物置于动物手术台的V形槽上,取侧卧位,碘伏再次喷洒消毒,铺一次性无菌单巾。取膝关节外侧髌旁入路,纵行切开皮肤长约6cm,逐层切开皮下组织、关节囊,将髌骨向内侧脱位,显露股骨滑车;a. After extracting the bone marrow, cut the hair with a hair clipper on the opposite knee to prepare the skin. The size of the skin preparation is about 40cm×30cm. Use sterile gauze dipped in antibacterial hand sanitizer to repeatedly scrub the operation area until it is clean and free of dirt, and spray the operation area with an iodophor pot . Place the operated animal on the V-shaped groove of the animal operating table, take the side lying position, spray iodine again for disinfection, and lay a disposable sterile towel. Take the parapatellar approach on the lateral side of the knee joint, incise the skin longitudinally about 6 cm long, incise the subcutaneous tissue and joint capsule layer by layer, dislocate the patella medially, and expose the femoral trochlea;

b.用直径为8mm的自制软骨缺损套筒于股骨滑车钻一个环形的软骨缺损,深度与关节透明软骨层厚度一致。利用眼科剪将环内透明软骨剪碎呈网状,小刮匙刮除剪碎的透明软骨,并保证钙化软骨层结构的完整,并确保基底无骨髓血渗出,修整缺损的底部及边缘,制备直径为8mm的全厚软骨缺损模型;b. Use a self-made cartilage defect sleeve with a diameter of 8 mm to drill a circular cartilage defect in the femoral trochlea, the depth of which is consistent with the thickness of the hyaline cartilage layer. Use ophthalmic scissors to cut the hyaline cartilage in the ring into a mesh shape, scrape off the shredded hyaline cartilage with a small curette, and ensure the integrity of the calcified cartilage layer structure, and ensure that there is no bone marrow blood seeping out of the base, and trim the bottom and edge of the defect. Prepare a full-thickness cartilage defect model with a diameter of 8mm;

c.用生理盐水脉冲枪冲洗造模区域以清除软骨碎削,将10μl氧化透明质酸溶液加入复合细胞的II型胶原蛋白凝胶中。神经剥离子搅拌均匀后植入软骨缺损部位,并塑形使凝胶表面与软骨表面平齐,刮除周围多余凝胶,静置2min待凝胶复合物充分成胶。复位髌骨并被动活动数次膝关节见凝胶块附着牢固,复位髌骨可吸收线加强缝合内侧支持带后脉冲冲洗,逐层缝合皮下及皮肤;c. Rinse the modeling area with a saline pulse gun to remove cartilage fragmentation, and add 10 μl of oxidized hyaluronic acid solution to the type II collagen gel of composite cells. The nerve stripper was stirred evenly and implanted in the cartilage defect site, and shaped to make the gel surface flush with the cartilage surface, scrape off excess gel around it, and let it stand for 2 minutes until the gel complex was fully gelled. Restore the patella and passively move the knee joint several times to see that the gel block is firmly attached. Restore the patella with absorbable suture to reinforce the suture of the medial retinaculum, then pulse flushing, and suture the subcutaneous and skin layer by layer;

d.术后即刻予鹿醒宁1支肌肉注射催醒,兽用青霉素钾400万单位肌注预防感染。术后膝关节不做固定,每日术区碘伏消毒2次,肌注抗生素2次(兽用青霉素钾400万单位)。常规饮食饲养,每日观察动物基本情况、伤口愈合情况及行走步态等。术后4头贵州小香猪由于麻醉相关死亡(n=2),关节脱位(n=1)及术后感染(n=1)而脱离研究系列。因此,一共36头贵州小香猪完成了全部的手术及术后观察评估,因此本研究暂时终止了术后12个月的长期随访,仅随访了术后1、3及6月的修复效果。剩余的36头小香猪在术后7天基本恢复正常的行走步态,术后10天左右手术切口达甲级愈合。1月随访组,取材时间为术后33±3天;3月随访组,取材时间为术后92±1天;6月随访组,取材时间为术后183±5天。d. Immediately after the operation, give Luxingning 1 intramuscular injection to wake up, and veterinary penicillin potassium 4 million units intramuscular injection to prevent infection. The knee joint was not fixed after the operation, and the operation area was disinfected twice a day with povidone iodine, and antibiotics were injected intramuscularly twice (veterinary penicillin potassium 4 million units). The animals were fed with a regular diet, and the basic conditions, wound healing and walking gait of the animals were observed daily. Four Guizhou miniature pigs were dropped out of the study series due to anesthesia-related death (n=2), joint dislocation (n=1) and postoperative infection (n=1). Therefore, a total of 36 Guizhou Xiaoxiang pigs completed all operations and postoperative observation and evaluation. Therefore, this study temporarily terminated the long-term follow-up for 12 months after operation, and only followed up the repair effect at 1, 3 and 6 months after operation. The remaining 36 small fragrant pigs basically returned to normal walking gait 7 days after the operation, and the surgical incisions healed to grade A about 10 days after the operation. In the 1-month follow-up group, the data collection time was 33±3 days after operation; in the 3-month follow-up group, the data collection time was 92±1 days after operation; in the 6-month follow-up group, the data collection time was 183±5 days after operation.

(1)MRI评分(1) MRI score

采用改良软骨修复组织MR观察评分系统(Modified magnetic resonanceobservation of cartilage repair tissue score,MOCART),对软骨缺损的修复效果进行半定量评分,其具体的评分标准如表1所示:The modified magnetic resonance observation of cartilage repair tissue score (Modified magnetic resonance observation of cartilage repair tissue score, MOCART) was used to semi-quantitatively score the repair effect of cartilage defects. The specific scoring criteria are shown in Table 1:

表1.改良软骨修复组织MR观察评分系统(MOCART)Table 1. Modified cartilage repair tissue MR observation scoring system (MOCART)

其评分结果如表2和图10中A所示,结果显示,空白对照组和实验组在术后1、3及6月MOCART评分分别为10±0和53.5±4.74(n=10,p<0.001);42±4.83和89.5±5.99(n=10,p<0.001);以及64±6.99和96±5.16(n=10,p<0.001)。The scoring results are shown in Table 2 and A in Figure 10. The results showed that the MOCART scores of the blank control group and the experimental group were 10 ± 0 and 53.5 ± 4.74 (n=10, p< 0.001); 42±4.83 and 89.5±5.99 (n=10, p<0.001); and 64±6.99 and 96±5.16 (n=10, p<0.001).

表2.软骨修复组织MOCART评分Table 2. MOCART score of cartilage repair tissue

值被表示为平均值±SD,Mann-Whitney’s U-test was used.*p<0.05(Treat.Vs.Cont.)Values are expressed as mean ± SD, Mann-Whitney’s U-test was used. *p<0.05 (Treat.Vs.Cont.)

a在原始的MOCART中,软骨下骨板被钙化层取代. a In the original MOCART, the subchondral bone plate was replaced by a calcified layer.

结果表明,使用本发明制备的(II型胶原蛋白-氧化透明质酸水凝胶复合自体骨髓浓缩有核细胞修复软骨效果更好。The results show that using the (II collagen-oxidized hyaluronic acid hydrogel compounded with autologous bone marrow concentrated nucleated cells prepared by the present invention has a better effect on cartilage repair.

(2)改良O’Driscoll组织学评分:采用改良O’Driscoll组织学评分对2组实验动物软骨缺损修复效果进行半定量分析,结果如表3和图10中B所示。对照组与治疗组在术后1、3及6月改良O’Driscoll组织学评分分别为:0 vs 13.3±2.21(n=10,p<0.001);6.1±2.02vs 16.8±1.4(n=10,p<0.001)及8±1.49 vs 17.6±1.26(n=10,p<0.001)。表面治疗组损伤软骨修复效果较对照组更优。(2) Modified O'Driscoll histological score: The modified O'Driscoll histological score was used to semi-quantitatively analyze the cartilage defect repair effect of the experimental animals in the two groups, and the results are shown in Table 3 and B in Figure 10. The modified O'Driscoll histological scores of the control group and the treatment group at 1, 3 and 6 months after operation were: 0 vs 13.3±2.21 (n=10, p<0.001); 6.1±2.02vs 16.8±1.4 (n=10 , p<0.001) and 8±1.49 vs 17.6±1.26 (n=10, p<0.001). The repair effect of damaged cartilage in the surface treatment group was better than that in the control group.

表3.软骨修复组织改良O’Driscoll组织学评分Table 3. Modified O’Driscoll histological score of cartilage repair tissue

值被表示为平均值±SD,Mann-Whitney’s U-test was used.*p<0.05(Treat.Vs.Cont.)Values are expressed as mean ± SD, Mann-Whitney’s U-test was used. *p<0.05 (Treat.Vs.Cont.)

(4)改良ICRS组织学评分:使用改良ICRS组织学评分对软骨缺损修复效果进行评价分析,从缺损修复程度、新生组织与邻近软骨整合、修复组织颜色、大体观以及修复组织力学强度等方面进行评估分析,结果如表4所示。对照组及治疗组在术后1、3及6月改良ICRS组织学评分分别为:0 vs 16.6±1.78(n=10,p<0.001);11.3±2.71 vs 19.3±1.64(n=10,p<0.001)以及15.1±1.85 vs 19.9±0.32(n=10,p<0.001)。(4) Modified ICRS histological score: The modified ICRS histological score was used to evaluate and analyze the repair effect of cartilage defects, including the degree of defect repair, the integration of new tissue and adjacent cartilage, the color of the repaired tissue, the general appearance, and the mechanical strength of the repaired tissue. The evaluation analysis, the results are shown in Table 4. The modified ICRS histological scores of the control group and the treatment group at 1, 3 and 6 months after operation were: 0 vs 16.6±1.78 (n=10, p<0.001); 11.3±2.71 vs 19.3±1.64 (n=10, p<0.001); <0.001) and 15.1±1.85 vs 19.9±0.32 (n=10, p<0.001).

表4.软骨修复组织改良ICRS组织学评分Table 4. Modified ICRS histological score of cartilage repair tissue

Values were presented as mean±SD,Mann-Whitney’s U-test was used.*p<0.05(Treat.Vs.Cont.)Values were presented as mean±SD, Mann-Whitney’s U-test was used.*p<0.05(Treat.Vs.Cont.)

上述结果表明,通过氧化透明质酸-II型胶原仿生凝胶复合自体浓缩骨髓有核细胞对贵州小香猪软骨缺损具有良好的修复效果。软骨缺损区域被软骨样新生修复组织填充,修复组织表面平整,与邻近正常软骨整合良好。基质中细胞与正常软骨细胞形态相似,可见分裂现象,具有自我更新能力,间充质干细胞成软骨分化。修复组织内II型胶原、GAG含量明显高于空白对照组,其MOCART评分、O’Driscoll组织学评分及ICRS组织学评分也明显优于空白对照组,有临床转化的潜能。其原理是:将透明质酸通过高碘酸钠氧化改性透明质酸,将其羟基氧化成醛基,氧化透明质酸上的醛基与II型胶原蛋白上的氨基通过Schiff'sbase反应,发生化学交联而成凝胶(图11所示),该方法克服了透明质酸不能与II型胶原蛋白发生聚合反应的问题。The above results indicated that the oxidized hyaluronic acid-type II collagen biomimetic gel compounded with autologous enriched bone marrow nucleated cells had a good repair effect on cartilage defects in Guizhou Xiaoxiang pigs. The cartilage defect area is filled with cartilage-like new repair tissue, the surface of the repair tissue is flat, and it is well integrated with the adjacent normal cartilage. The cells in the stroma are similar in shape to normal chondrocytes, with division phenomenon, self-renewal ability, and chondrogenic differentiation of mesenchymal stem cells. The content of type II collagen and GAG in the repaired tissue was significantly higher than that of the blank control group, and its MOCART score, O’Driscoll histological score and ICRS histological score were also significantly better than the blank control group, which has the potential of clinical transformation. The principle is: oxidize hyaluronic acid through sodium periodate to modify hyaluronic acid, oxidize its hydroxyl group into aldehyde group, and react the aldehyde group on hyaluronic acid with the amino group on type II collagen through Schiff's base. Chemical cross-linking occurs to form a gel (as shown in Figure 11), this method overcomes the problem that hyaluronic acid cannot polymerize with type II collagen.

最后说明的是,以上优选实施例仅用以说明本发明的技术方案而非限制,尽管通过上述优选实施例已经对本发明进行了详细的描述,但本领域技术人员应当理解,可以在形式上和细节上对其作出各种各样的改变,而不偏离本发明权利要求书所限定的范围。Finally, it should be noted that the above preferred embodiments are only used to illustrate the technical solutions of the present invention and not to limit them. Although the present invention has been described in detail through the above preferred embodiments, those skilled in the art should understand that it can be described in terms of form and Various changes may be made in the details without departing from the scope of the invention defined by the claims.

Claims (8)

1.基于氧化透明质酸-II型胶原和自体浓缩骨髓有核细胞的关节软骨修复材料,其特征在于,由氧化透明质酸、II型胶原蛋白和自体浓缩骨髓有核细胞制成。1. The articular cartilage repair material based on oxidized hyaluronic acid-type II collagen and autologous concentrated bone marrow nucleated cells, characterized in that it is made of oxidized hyaluronic acid, type II collagen and autologous concentrated bone marrow nucleated cells. 2.根据权利要求1所述基于氧化透明质酸-II型胶原和自体浓缩骨髓有核细胞的关节软骨修复材料,其特征在于:氧化透明质酸、II型胶原蛋白和自体浓缩骨髓有核细胞的加入量按每2×106个自体浓缩骨髓有核细胞加入100mg II型胶原蛋白凝胶和10μl浓度为100mg/ml的氧化透明质酸溶液。2. The articular cartilage repair material based on oxidized hyaluronic acid-type II collagen and autologous concentrated bone marrow nucleated cells according to claim 1, characterized in that: oxidized hyaluronic acid, type II collagen and autologous concentrated bone marrow nucleated cells The amount of addition is based on the addition of 100 mg of type II collagen gel and 10 μl of oxidized hyaluronic acid solution with a concentration of 100 mg/ml for every 2×10 6 autologous concentrated bone marrow nucleated cells. 3.根据权利要求1基于氧化透明质酸-II型胶原和自体浓缩骨髓有核细胞的关节软骨修复材料,其特征在于:所述100mg/ml的氧化透明质酸由每100mg氧化透明质酸加入1mlPBS溶液,经完全溶解制得。3. According to claim 1, the articular cartilage repair material based on oxidized hyaluronic acid-type II collagen and autologous concentrated bone marrow nucleated cells is characterized in that: the oxidized hyaluronic acid of 100mg/ml is added by every 100mg oxidized hyaluronic acid 1ml of PBS solution, prepared by complete dissolution. 4.根据权利要求1~3任一项所述基于氧化透明质酸-II型胶原和自体浓缩骨髓有核细胞的关节软骨修复材料,其特征在于:所述II型胶原蛋白由以下方法制备:将冻干软骨粉按质量体积比为20:1(g:L)用浓度为4M盐酸胍溶液搅拌混悬,搅拌后置于4℃条件下,消化软骨粉基质中的粘多糖至匀浆状态;消化完全后,将消化产物在4℃、8000rpm条件下离心20min,弃上清液,收集沉淀物,加水溶解,然后加入相当于盐酸胍溶液体积3/50倍的醋酸,加入相当于冻干软骨粉重量0.1倍的胃蛋白酶,加水至终体积为盐酸胍溶液的2倍,调节pH值于2.5-3之间,然后在4℃条件下消化48h;消化完毕后于立式高速离心机中8000rpm离心20min,弃沉淀,收集上清液;接着向上清液中缓慢倒入浓度为1.5M的NaOH溶液并搅拌至pH值为7.5时停止倒注,加入NaCl使其终浓度为3M,4℃条件下,8000rpm离心20min,收集沉淀物;沉淀物分装至透析袋中待透析液电导率,接近纯水电导率时结束透析;将透析袋内粘稠胶状溶液在4℃条件下,立式高速离心机8000rpm离心20min,收集沉淀物至无菌容量瓶中,加入0.15mol/L的盐酸溶液,溶解3天后白色沉淀蛋白分散、溶解呈凝胶状,搅拌均匀,分装,冻干,备用。4. The articular cartilage repair material based on oxidized hyaluronic acid-type II collagen and autologous concentrated bone marrow nucleated cells according to any one of claims 1 to 3, characterized in that: the type II collagen is prepared by the following method: Stir and suspend the freeze-dried cartilage powder with a 4M guanidine hydrochloride solution at a mass volume ratio of 20:1 (g:L), and place it at 4°C after stirring to digest the mucopolysaccharide in the cartilage powder matrix to a homogenate state ; After the digestion is complete, centrifuge the digested product at 4°C and 8000rpm for 20min, discard the supernatant, collect the precipitate, add water to dissolve it, then add acetic acid equivalent to 3/50 times the volume of the guanidine hydrochloride solution, add an amount equivalent to lyophilized Add pepsin with 0.1 times the weight of cartilage powder, add water until the final volume is twice that of the guanidine hydrochloride solution, adjust the pH value between 2.5-3, and then digest at 4°C for 48 hours; after digestion, place in a vertical high-speed centrifuge Centrifuge at 8000rpm for 20min, discard the precipitate, and collect the supernatant; then slowly pour 1.5M NaOH solution into the supernatant and stir until the pH value is 7.5, stop pouring, add NaCl to make the final concentration 3M, 4°C Centrifuge at 8000rpm for 20min under the same conditions to collect the sediment; divide the sediment into the dialysis bag and stop the dialysis when the conductivity of the dialysate is close to the conductivity of pure water; put the viscous colloidal solution in the dialysis bag at 4°C, immediately Centrifuge at 8000rpm for 20min in a high-speed centrifuge, collect the precipitate into a sterile volumetric flask, add 0.15mol/L hydrochloric acid solution, and dissolve the white precipitated protein after 3 days. Disperse and dissolve into a gel, stir evenly, subpackage, freeze-dry, spare. 5.根据权利要求1~3任一项所述基于氧化透明质酸-II型胶原和自体浓缩骨髓有核细胞的关节软骨修复材料,其特征在于,所述氧化透明质酸由以下方法制备:配制成质量分数为2%的透明质酸溶液,然后加入0.1g/ml的高碘酸钠溶液,搅拌,避光条件下完全氧化反应6小时,然后加入乙二醇终止反应,再将反应液灌入透析袋中至电导率接近纯水时结束透析,获得氧化透明质酸。5. The articular cartilage repair material based on oxidized hyaluronic acid-type II collagen and autologous concentrated bone marrow nucleated cells according to any one of claims 1 to 3, wherein the oxidized hyaluronic acid is prepared by the following method: Prepare a hyaluronic acid solution with a mass fraction of 2%, then add 0.1g/ml sodium periodate solution, stir, and completely oxidize for 6 hours under dark conditions, then add ethylene glycol to terminate the reaction, and then add the reaction solution Pour it into a dialysis bag until the conductivity is close to pure water and end the dialysis to obtain oxidized hyaluronic acid. 6.根据权利要求1~3任一项所述基于氧化透明质酸-II型胶原和自体浓缩骨髓有核细胞的关节软骨修复材料,其特征在于,自体浓缩骨髓有核细胞由以下方法制备:对目前动物进行麻醉,然后用已经使用1000U/ml肝素预湿的注射器抽取骨髓血,然后将抽取的抗凝骨髓液加入等体积的无菌PBS液,混匀,混匀后将骨髓液沿管壁缓慢注入到含等体积的浓度为1.073g/ml的Percoll胞分离液中,注入过程保持分离液与混合液体之间界面的完整,接着采用Percoll密度梯度离心法获取自体浓缩骨髓有核细胞,先以2000rpm的速度离心混合液体15min,吸取有核细胞层,加入PBS溶液洗涤吸取的有核细胞,以1500rpm的速度离心洗涤细胞5min,弃上清;再次加入PBS吹打洗涤细胞,1000rpm速度离心5min,弃上清,加入PBS重悬即得。6. The articular cartilage repair material based on oxidized hyaluronic acid-type II collagen and autologous concentrated bone marrow nucleated cells according to any one of claims 1 to 3, characterized in that the autologous concentrated bone marrow nucleated cells are prepared by the following method: Anesthetize the current animal, then use a syringe that has been pre-wetted with 1000U/ml heparin to draw bone marrow blood, then add the extracted anticoagulant bone marrow fluid to an equal volume of sterile PBS solution, mix well, and then pour the bone marrow fluid along the tube The wall was slowly injected into an equal volume of Percoll cell separation liquid with a concentration of 1.073g/ml. During the injection process, the interface between the separation liquid and the mixed liquid was kept intact, and then Percoll density gradient centrifugation was used to obtain autologous concentrated bone marrow nucleated cells. First centrifuge the mixed liquid at 2000rpm for 15min, absorb the nucleated cell layer, add PBS solution to wash the absorbed nucleated cells, centrifuge and wash the cells at 1500rpm for 5min, discard the supernatant; add PBS again to blow and wash the cells, and centrifuge at 1000rpm for 5min , discard the supernatant, and add PBS to resuspend. 7.权利要求1~6任一项所述基于氧化透明质酸-II型胶原和自体浓缩骨髓有核细胞的关节软骨修复材料的制备方法,其特征在于,具体步骤如下:将自体浓缩骨髓有核细胞先与II型胶原蛋白混合,然后再加入氧化透明质酸进行交联。7. The preparation method of the articular cartilage repair material based on oxidized hyaluronic acid-type II collagen and autologous concentrated bone marrow nucleated cells according to any one of claims 1 to 6, characterized in that, the specific steps are as follows: the autologous concentrated bone marrow has Nuclear cells are first mixed with type II collagen before adding oxidized hyaluronic acid for cross-linking. 8.权利要求1~6任一项所述关节软骨修复材料在制备关节软骨修复材料中的应用。8. The use of the articular cartilage repair material according to any one of claims 1 to 6 in the preparation of articular cartilage repair materials.
CN201711446501.2A 2017-12-27 2017-12-27 Articular cartilage repair materials and preparation method based on oxidized hyaluronic acid-II Collagen Type VI and self concentration bone marrow nucleated cell Expired - Fee Related CN108096632B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711446501.2A CN108096632B (en) 2017-12-27 2017-12-27 Articular cartilage repair materials and preparation method based on oxidized hyaluronic acid-II Collagen Type VI and self concentration bone marrow nucleated cell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711446501.2A CN108096632B (en) 2017-12-27 2017-12-27 Articular cartilage repair materials and preparation method based on oxidized hyaluronic acid-II Collagen Type VI and self concentration bone marrow nucleated cell

Publications (2)

Publication Number Publication Date
CN108096632A true CN108096632A (en) 2018-06-01
CN108096632B CN108096632B (en) 2019-02-05

Family

ID=62213872

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711446501.2A Expired - Fee Related CN108096632B (en) 2017-12-27 2017-12-27 Articular cartilage repair materials and preparation method based on oxidized hyaluronic acid-II Collagen Type VI and self concentration bone marrow nucleated cell

Country Status (1)

Country Link
CN (1) CN108096632B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109589451A (en) * 2018-11-19 2019-04-09 浙江星月生物科技股份有限公司 A kind of one-step method regenerating bone or cartilage repairing composite and preparation method thereof
CN113476657A (en) * 2021-06-21 2021-10-08 四川大学 Collagen-based hydrogel for cartilage tissue engineering and preparation method thereof
CN114870092A (en) * 2022-05-20 2022-08-09 广州骊贝生物科技有限公司 Bone substitute complex and preparation method and application thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6623963B1 (en) * 1999-12-20 2003-09-23 Verigen Ag Cellular matrix
CN1539514A (en) * 2003-11-03 2004-10-27 刘永庆 Method for preparing multifunctional biological repair material
CN101091804A (en) * 2007-07-18 2007-12-26 戴江华 Method for constructing tissue-engineering bone by pouring stem cell of inducing bone marrow ground substance into vivo
CN101301490A (en) * 2008-06-27 2008-11-12 四川大学 A kind of preparation method of medical grade type II collagen
CN102188748A (en) * 2011-04-29 2011-09-21 成都军区昆明总医院 Novel chondrocyte epimatrix membrane and preparation method thereof
CN102488925A (en) * 2011-12-29 2012-06-13 成都普川生物医用材料股份有限公司 Injectable articular cartilage tissue repair material and its preparation method

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6623963B1 (en) * 1999-12-20 2003-09-23 Verigen Ag Cellular matrix
CN1539514A (en) * 2003-11-03 2004-10-27 刘永庆 Method for preparing multifunctional biological repair material
CN101091804A (en) * 2007-07-18 2007-12-26 戴江华 Method for constructing tissue-engineering bone by pouring stem cell of inducing bone marrow ground substance into vivo
CN101301490A (en) * 2008-06-27 2008-11-12 四川大学 A kind of preparation method of medical grade type II collagen
CN102188748A (en) * 2011-04-29 2011-09-21 成都军区昆明总医院 Novel chondrocyte epimatrix membrane and preparation method thereof
CN102488925A (en) * 2011-12-29 2012-06-13 成都普川生物医用材料股份有限公司 Injectable articular cartilage tissue repair material and its preparation method

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109589451A (en) * 2018-11-19 2019-04-09 浙江星月生物科技股份有限公司 A kind of one-step method regenerating bone or cartilage repairing composite and preparation method thereof
CN109589451B (en) * 2018-11-19 2022-03-08 浙江星月生物科技股份有限公司 One-step cartilage regeneration and repair compound and preparation method thereof
CN113476657A (en) * 2021-06-21 2021-10-08 四川大学 Collagen-based hydrogel for cartilage tissue engineering and preparation method thereof
CN114870092A (en) * 2022-05-20 2022-08-09 广州骊贝生物科技有限公司 Bone substitute complex and preparation method and application thereof
CN114870092B (en) * 2022-05-20 2023-08-22 广州骊贝生物科技有限公司 Bone substitute complex, preparation method and application thereof

Also Published As

Publication number Publication date
CN108096632B (en) 2019-02-05

Similar Documents

Publication Publication Date Title
Yin et al. Induction of mesenchymal stem cell chondrogenic differentiation and functional cartilage microtissue formation for in vivo cartilage regeneration by cartilage extracellular matrix-derived particles
Beck et al. Approaching the compressive modulus of articular cartilage with a decellularized cartilage-based hydrogel
CN113398332B (en) A 3D biomimetic biological scaffold containing stem cell exosomes and its application
JP6980004B2 (en) Cartilage regeneration composition and its manufacturing method
CN106676065A (en) Adipose tissue source exosome gel, preparation method and application
CN111849882A (en) Mesenchymal stem cell exosome and preparation method and application thereof
Zhang et al. Bone marrow-derived mesenchymal stem cells versus bone marrow nucleated cells in the treatment of chondral defects
CN110124107B (en) A PLGA cell scaffold for articular cartilage repair and its preparation method and application
CN110975010A (en) A kind of placental tissue matrix material and preparation method thereof
CN106492194A (en) A kind of stem cell excretion body preparation and its preparation method and application
CN111494719A (en) A new type of bone tissue engineering scaffold and preparation method thereof
Liu et al. Cell-free scaffolds functionalized with bionic cartilage acellular matrix microspheres to enhance the microfracture treatment of articular cartilage defects
CN108096632A (en) Articular cartilage repair materials and preparation method based on oxidized hyaluronic acid-II Collagen Type VIs and self concentration bone marrow nucleated cell
Shetty et al. Autologous collagen induced chondrogenesis (ACIC: Shetty–Kim technique)–a matrix based acellular single stage arthroscopic cartilage repair technique
CN111297901B (en) Preparation method and application of autologous fat glue and mesenchymal stem cells derived from autologous fat glue
CN115404209B (en) Marrow mesenchymal stem cell extracellular vesicle and acquisition and application thereof
CN106421917A (en) Method for preparing composition for repairing cartilage injuries
Wan et al. Injectable biomimetic hydrogel based on modified chitosan and silk fibroin with decellularized cartilage extracellular matrix for cartilage repair and regeneration
CN105833348A (en) Method for preparing hBMSCs/hyaline cartilage particle/calcium alginate gel compound and application thereof
CN111607560A (en) A method for culturing adipose stem cells and its application in arthritis
CN115957378B (en) Bone repair composition and preparation method and application thereof
KR20110105759A (en) Combination of Blood and Ideal Calcium Phosphate Ceramic Particles
CN111235091A (en) Extraction reagent and extraction method for human autologous fat vascular stroma component SVF
CN118203701A (en) Application of injectable bionic hydrogel in preparation of epiphyseal plate repair material
CN103013910A (en) Human degenerative intervertebral disc cartilage endplate stem cell, preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20190205